C. Schwarz

10.0k total citations · 1 hit paper
110 papers, 4.1k citations indexed

About

C. Schwarz is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, C. Schwarz has authored 110 papers receiving a total of 4.1k indexed citations (citations by other indexed papers that have themselves been cited), including 59 papers in Pulmonary and Respiratory Medicine, 29 papers in Infectious Diseases and 23 papers in Epidemiology. Recurrent topics in C. Schwarz's work include Cystic Fibrosis Research Advances (52 papers), Antifungal resistance and susceptibility (22 papers) and Tracheal and airway disorders (14 papers). C. Schwarz is often cited by papers focused on Cystic Fibrosis Research Advances (52 papers), Antifungal resistance and susceptibility (22 papers) and Tracheal and airway disorders (14 papers). C. Schwarz collaborates with scholars based in Germany, United States and France. C. Schwarz's co-authors include Hendrik N. Poinar, Régis Debruyne, Christine King, G. Brian Golding, Gerard D. Wright, Mariya Morar, Vanessa M. D’Costa, Grant D. Zazula, Duane Froese and Lindsay Kalan and has published in prestigious journals such as Nature, Science and The Lancet.

In The Last Decade

C. Schwarz

97 papers receiving 4.0k citations

Hit Papers

Antibiotic resistance is ancient 2011 2026 2016 2021 2011 500 1000 1.5k

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Schwarz Germany 23 1.3k 890 868 715 700 110 4.1k
Toshio Takahashi Japan 39 1.2k 0.9× 403 0.5× 718 0.8× 230 0.3× 430 0.6× 399 6.1k
Livia Leoni Italy 35 2.2k 1.7× 215 0.2× 939 1.1× 888 1.2× 233 0.3× 105 4.2k
Mark J. Walker Australia 57 3.6k 2.8× 338 0.4× 1.1k 1.3× 691 1.0× 286 0.4× 293 13.5k
Yoshimasa Yamamoto Japan 35 1.1k 0.9× 610 0.7× 972 1.1× 111 0.2× 112 0.2× 220 4.5k
David Allison United Kingdom 31 2.0k 1.6× 301 0.3× 353 0.4× 230 0.3× 258 0.4× 104 3.4k
Melissa H. Brown Australia 42 3.3k 2.6× 453 0.5× 2.7k 3.1× 1.3k 1.8× 72 0.1× 123 7.0k
Lars E. P. Dietrich United States 40 3.6k 2.9× 189 0.2× 661 0.8× 1.0k 1.4× 337 0.5× 83 5.6k
Thomas Sicheritz‐Pontén Denmark 38 5.2k 4.2× 792 0.9× 1.4k 1.7× 1.1k 1.6× 81 0.1× 95 9.8k
R. Craig MacLean United Kingdom 47 2.7k 2.2× 657 0.7× 2.0k 2.3× 2.9k 4.1× 55 0.1× 97 6.5k
Christine E. R. Dodd United Kingdom 37 2.5k 2.0× 263 0.3× 322 0.4× 513 0.7× 103 0.1× 95 5.3k

Countries citing papers authored by C. Schwarz

Since Specialization
Citations

This map shows the geographic impact of C. Schwarz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Schwarz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Schwarz more than expected).

Fields of papers citing papers by C. Schwarz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Schwarz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Schwarz. The network helps show where C. Schwarz may publish in the future.

Co-authorship network of co-authors of C. Schwarz

This figure shows the co-authorship network connecting the top 25 collaborators of C. Schwarz. A scholar is included among the top collaborators of C. Schwarz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Schwarz. C. Schwarz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fèvre, A. Le, A. Chbihi, J. Łukasik, et al.. (2025). Isotopic transparency in central Xe+Sn collisions at 100 MeV/nucleon. Physics Letters B. 868. 139749–139749.
2.
Burgel, Pierre‐Régis, Manfred Ballmann, Pavel Dřevı́nek, et al.. (2024). Considerations for the use of inhaled antibiotics for Pseudomonas aeruginosa in people with cystic fibrosis receiving CFTR modulator therapy. BMJ Open Respiratory Research. 11(1). e002049–e002049. 9 indexed citations
3.
Kamal, Elisabeth, et al.. (2024). Gene knock-out in Mycobacterium abscessus using Streptococcus thermophilus CRISPR/Cas. Journal of Microbiological Methods. 220. 106924–106924. 2 indexed citations
5.
Antoran, Aitziber, Marı́a Gómez, Roberto Fernández, et al.. (2023). Dot Immunobinding Assay for the Rapid Serodetection of Scedosporium/Lomentospora in Cystic Fibrosis Patients. Journal of Fungi. 9(2). 158–158. 8 indexed citations
6.
Antoran, Aitziber, Jean‐Philippe Bouchara, C. Schwarz, et al.. (2023). Microbiota and fungal-bacterial interactions in the cystic fibrosis lung. FEMS Microbiology Reviews. 47(3). 9 indexed citations
7.
Lewin, Astrid, Elisabeth Kamal, Torsten Semmler, et al.. (2021). Genetic diversification of persistent Mycobacterium abscessus within cystic fibrosis patients. Virulence. 12(1). 2415–2429. 18 indexed citations
8.
Schwarz, C., Patience Eschenhagen, & Jean‐Philippe Bouchara. (2021). Emerging Fungal Threats in Cystic Fibrosis. Mycopathologia. 186(5). 639–653. 15 indexed citations
9.
Naehrlich, Lutz, et al.. (2020). Risk factors for respiratory Aspergillus fumigatus in German Cystic Fibrosis patients and impact on lung function. Scientific Reports. 10(1). 18999–18999. 34 indexed citations
10.
Grehn, Claudia, et al.. (2020). Urban Life as Risk Factor for Aspergillosis. Frontiers in Cellular and Infection Microbiology. 10. 601834–601834. 6 indexed citations
11.
Dřevı́nek, Pavel, Tacjana Pressler, Marco Cipolli, et al.. (2019). Antisense oligonucleotide eluforsen is safe and improves respiratory symptoms in F508DEL cystic fibrosis. Journal of Cystic Fibrosis. 19(1). 99–107. 49 indexed citations
12.
Eschenhagen, Patience & C. Schwarz. (2019). Patienten mit zystischer Fibrose werden erwachsen. Der Internist. 60(1). 98–108. 1 indexed citations
13.
Scheffold, Alexander, C. Schwarz, & Petra Bächer. (2017). Fungus-Specific CD4 T Cells as Specific Sensors for Identification of Pulmonary Fungal Infections. Mycopathologia. 183(1). 213–226. 15 indexed citations
14.
Sedlacek, Ludwig, Barbara Graf, C. Schwarz, et al.. (2015). Prevalence of Scedosporium species and Lomentospora prolificans in patients with cystic fibrosis in a multicenter trial by use of a selective medium. Journal of Cystic Fibrosis. 14(2). 237–241. 72 indexed citations
16.
Roehmel, Jobst, C. Schwarz, Anne Mehl, Philippe Stock, & Doris Staab. (2013). Hypersensitivity to antibiotics in patients with cystic fibrosis. Journal of Cystic Fibrosis. 13(2). 205–211. 30 indexed citations
17.
Bernhardt, Anne, et al.. (2013). Multilocus sequence typing of Scedosporium apiospermum and Pseudallescheria boydii isolates from cystic fibrosis patients. Journal of Cystic Fibrosis. 12(6). 592–598. 38 indexed citations
18.
Meyer, Rosan, C. Schwarz, & Neil Shah. (2012). A review on the diagnosis and management of food-induced gastrointestinal allergies : review articles. 25(1). 10–17. 9 indexed citations
19.
Poinar, Hendrik N., C. Schwarz, Ji Qi, et al.. (2005). Metagenomics to Paleogenomics: Large-Scale Sequencing of Mammoth DNA. Science. 311(5759). 392–394. 406 indexed citations
20.
Auer, Jana, Robert Berent, C Punzengruber, et al.. (2001). Early investigation of silver-coated Silzone heart valves prosthesis in 126 patients.. PubMed. 10(6). 717–23. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026